Madison Wisconsin lymphoma protocol
The Madison Winsconsin lymphoma protocol is a chemotherapy regimen[1].
Week 1:
- Vincristine 0.7 mg/m2 IV
- Asparaginase 400 IU/kg IM
- Pre-med with chlorphenamine: small-medium 2.5 - 5 mg IM; medium-large 5 - 10 mg IM
- Prednisolone 2 mg/kg PO SID
- Cimetidine 2 mg/kg PO BID
Week 2:
- Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl)
- Prednisolone 1.5 mg/kg PO SID
- Stop antacids: after week 2
Week 3:
- Vincristine 0.7 mg/m2 IV
- Prednisolone 1 mg/kg PO SID
Week 4:
- Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl) - for dogs < 10 Kg, use 1 mg/Kg dose of doxorubicin
- Pre-med with chlorphenamine and
- Metoclopramide 0.5-1 mg/kg IM/SC
- Prednisolone 0.5 mg/kg PO SID
Week 6:
- Vincristine 0.7 mg/m2 IV
Week 7:
- Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl)
Week 8:
- Vincristine 0.7 mg/m2 IV
Week 9:
- Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl)
- Pre-med with chlorphenamine + metoclopramide
Week 11:
- Vincristine 0.7 mg/m2 IV
Week 13:
- Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl)
Week 15:
- Vincristine 0.7 mg/m2 IV
Week 17:
- Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl)
- Pre-med with chlorphenamine + metoclopramide
Week 19:
- Vincristine 0.7 mg/m2 IV
Week 21:
- Cyclophosphamide 250 mg/m2 PO or IV (+ NaCl)
Week 23:
- Vincristine 0.7 mg/m2 IV
Week 25:
- Doxorubicin 30 mg/m2 IV (+ 0.9% NaCl)
- Pre-med with chlorphenamine + metoclopramide
Haematology should be performed prior to each dose and urinalysis after every cyclophosphamide dose. A full urinalysis should be performed after week 7.
A cardiac echocardiogram should be performed at the time of first and last doxorubicin dose.
All treatment is discontinued after week 25 if in complete remission.
If neutrophil count is < 3 × 109/L wait 5-7 days and repeat haematology before giving chemo.
If sterile haemorrhagic cystitis occurs on cyclophosphamide, discontinue and substitute Chlorambucil (1.4 mg/kg PO) for subsequently scheduled cyclophosphamide injections.
Administer L-asparaginase (400 IU/kg IM) with each vincristine injection until clinical remission is achieved.
References
- ↑ Spugnini EP et al (2011) Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 9:221